You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Dow
Express Scripts
McKinsey
AstraZeneca

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories, Inc. v. Indchemie Health Specialties PVT. LTD. (N.D. Ill. 2012)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Forest Laboratories, Inc. v. Indchemie Health Specialties PVT. LTD. (N.D. Ill. 2012)

Docket   Start Trial Date Filed 2012-03-14
Court District Court, N.D. Illinois Date Terminated 2013-12-19
Cause 35:271 Patent Infringement Assigned To Elaine E. Bucklo
Jury Demand None Referred To
Parties ALKEM LABORATORIES, LTD.; FOREST LABORATORIES HOLDINGS, LTD.; FOREST LABORATORIES, INC.; GLENMARK GENERICS INC.; GLENMARK GENERICS LTD.; GLENMARK PHARMACEUTICALS LTD; INDCHEMIE HEALTH SPECIALTIES PVT. LTD.; JANSSEN PHARMACEUTICA, N.V.; SERVICE LIST; TORRENT PHARMA INC; TORRENT PHARMACEUTICALS LTD; WATSON LABORATORIES, INC. (NV)
Patents 6,545,040
Attorneys Ashley Elizabeth LaValley; Christopher Stephen Casieri; David A. Steffes; David T. Pritikin; Deirdre Anne Fox; Elizabeth A.F. Morris; Elizabeth L Barbour; Frederick Christopher Laney; Imron T Aly; James Suh; Jeremy J. Edwards; Joel M Wallace; Kevin Earl Warner; Mark W. Wallin; Paul F. Stack; Russell E. Cass; Stephen J. Rosenfeld; Steven Arthur Maddox; Steven L Baron; Steven P. Mandell; Todd Lawrence Krause
Firms Chico & Nunes, P.C.; Knobbe Martens Olson & Bear LLP; Knobbe, Martens, Olson & Bear LLP; Mandell Menkes LLC; McNeely Hare & War; Niro, Haller & Niro; Niro, Scavone, Haller & Niro, Ltd.; Scharf Banks Marmor LLC; Stack & O'Connor Chartered
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories, Inc. v. Indchemie Health Specialties PVT. LTD.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Forest Laboratories, Inc. v. Indchemie Health Specialties PVT. LTD. (N.D. Ill. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-03-14 1 to the expiration of U.S. Patent No. 6,545,040 (the " '040 Patent"). … INFRINGEMENT OF U.S. PATENT NO. 6,545,040 14. Plaintiffs incorporate … 1. This is an action for patent infringement under the patent laws of the United States, Title…United States Patent and Trademark Office ("USPTO") issued the '040 Patent to Janssen Pharmaceutica…copy of the '040 Patent is attached hereto as Exhibit A. The '040 Patent was submitted to the External link to document
2012-06-12 86 allegations with respect to U.S. Patent No. 6,545,040 (‘040 patent), which covers the Bystolic drug.…generic versions of the patented Forest drug Bystolic3 before the drug’s patent expires. Bystolic reportedly…complex pharmaceutical patents and the entry of generic versions of the patent holder’s drugs are particularly…ingredients in the patent. Moreover, the issue of the obviousness of the ‘040 patent based on a specific…Brimonidine Patent Litig., 507 F. Supp. 2d 1381 (J.P.M.L. 2007) (same); In re Metoprolol Succinate Patent Litig External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.